XFOR - X4 Pharmaceuticals Inc (XFOR) Q1 2024 Earnings Call Transcript

2024-05-07 13:33:09 ET

X4 Pharmaceuticals Inc (XFOR)

Q1 2024 Results Conference Call

May 07, 2024 8:30 AM ET

Company Participants

Dan Ferry - IR

Paula Ragan - CEO

Adam Mostafa - CFO

Christophe Arbet-Engels - COO

Mark Baldry - CMO

Conference Call Participants

Stephen Willey - Stifel

Edward Tenthoff - Piper Sandler

Kristen Kluska - Cantor Fitzgerald

Swayampakula Ramakanth - H.C. Wainwright

David Bautz - Zacks Small Cap Research

Presentation

Operator

[Indiscernible] X4 Pharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question and answer session will follow the formal presentation. As a reminder, this conference is being recorded.

It's now my pleasure to introduce your host, Mr. Dan Ferry from LifeSci Advisors. Thank you, Mr. Ferry. You may begin.

Dan Ferry

Thank you, operator, and good morning everyone. Thank you for joining us today. Presenting on today’s call will be Dr. Paula Ragan; X4’s President and Chief Executive Officer, and company’s Chief Financial Officer, Adam Mostafa. Following prepared remarks, we will open the call to your questions and we’ll be joined by Chief Commercial Officer, Mark Baldry; Chief Medical Officer, Dr. Christophe Arbet-Engels; Chief Operating Officer, Mary DiBiase; and Chief Scientific Officer, Art Taveras; and Jose Juves. Head of Corporate & Patient Affairs ...

For further details see: